ITOCNasdaqElectromedical & Electrotherapeutic Apparatus

iTonic Holdings Ltd

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 30, 2026

$3.71−0.13 (-3.39%)

Close on Oct 19, 2026

Market cap: –
P/E (TTM): –
Dividend yield: –

iTonic Holdings Ltd cash flow statement

AnnualQuarterlyTTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31
Stock-Based Compensation	2.95	–	–	–
Deferred Income Taxes	–	0.02	-0.02	0.00
Change in Accounts Receivable	-0.05	-0.12	0.21	-0.28
Change in Inventory	0.07	-0.07	0.03	-0.06
Change in Accounts Payable	0.06	-0.01	0.01	-0.01
Change in Unearned Revenue	0.01	0.09	-0.10	0.14
Operating Cash Flow	-3.23	-0.78	-0.06	-0.12
Capital Expenditures	0.00	0.00	–	–
Purchase of Investments	-1.40	–	–	–
Investing Cash Flow	-1.35	0.00	–	–
Dividends Paid	-0.01	–	–	-0.40
Financing Cash Flow	-0.09	6.71	0.22	0.08
Foreign Exchange Rate Adjustments	0.01	0.00	0.00	-0.03
Net Change in Cash	-4.67	5.93	0.16	-0.06
Free Cash Flow	-3.24	-0.78	–	–
Interest Paid	0.01	0.01	–	–

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, FY2025

Gross margin: 62.6%
Operating margin: -991.7%
Net margin: -974.7%
Return on equity, FY2025: -82.8%

Financial strength

Current ratio: 17.39
Debt to equity: –
Debt to assets: –
Cash to current liabilities: 56.8%

Valuation

P/E ratio: –
Price to sales: –
Price to book: –
Dividend yield: –